Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: Clinicopathological correlations

Genes Chromosomes and Cancer

Volumn 18, Issue 2, 1997, Pages 75-83

  Chenevix Trench, Georgia ^a,g   Kerr, Judith ^a   Hurst, Terry ^b   Shih, Yang Chia ^a   Purdie, David ^a   Bergman, Lee ^a   Friedlander, Michael ^c   Sanderson, Barbara ^b   Zournazi, Anna ^a   Coombs, Tania ^a   Leary, Jennifer A ^d   Crawford, Eric ^e   Shelling, Andrew N ^f   Cooke, Inez ^f   Ganesan, Trivadi S ^f   Searle, Jeffrey ^g   Choi, Chan ^h   Barrett, J Carl ^h   Khoo, Soo Keat ^b   Ward, Bruce ^b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^g ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^h NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BENIGN TUMOR; CANCER STAGING; CANCER SURVIVAL; CHROMOSOMAL LOCALIZATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; OVARY ADENOCARCINOMA; OVARY TUMOR; PRIORITY JOURNAL;

CHROMOSOME DELETION; FEMALE; GENES, RAS; HETEROZYGOTE; HUMANS; MUTATION; NEOPLASM STAGING; OVARIAN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0031014476     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199702)18:2<75::AID-GCC1>3.0.CO;2-Y     Document Type: Article

References (50)

1. Allan GJ, Cottrell S, Trowsdale J, Foulkes WD (1994) Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with any mutations in APC at 5q21-22. Hum Mutat 3:283-291.
2. Cao Q, Cedrone E, Barrett C, Wang N (1993) Suppression of in vitro Growth of ovarian carcinoma cells by microcell-mediated chromosome 11 transfer, Am J Hum Genet 53 (Suppl):A1517.
3. Chenevix-Trench G, Leary J, Kerr J, Michel J, Kefford R, Hurst T, Parson PG, Friendlander M, Khoo S-K (1992) Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Oncogene 7:1059- 1065.
4. Chenivex- Trench G, Kerr J, Frienlander M, Hurst T, Sanderson B, Coglan M, Ward B, Leary of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors. Am J Hum Genet 55:143-149.
5. Cheng PC, Gosewehr JA, Kim TM, Velicescu M, Wan M, Zheng J, Felix JC, Cofer KF, Luo P, Biela BH, Godorov G, Dubeat L (1996) Porential role of the inactivated X chromosome in ovarian epithlial tumor development J Natl Cancer Inst 88:510-518.
6. Cliby W, Ritland S, Hattmann L, Dodson M, Halling KC, Keeney G, Podratz KC, Jenkins RB (1993) Human epithelial ovarian cancer allelotype, Cancer Res 53:2393-2398.
7. Cooke IE, Shelling AN, Le Meuth VG, Charnock FML, Ganesan TS (1996) Allele loss on chtomosome 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer. Genet Chromosom Cancer 15:223-233(1996).
8. Eccles DM, Russel SEH, Haites NE, The ABC Ovarian Cancer Gnetics Group (1992) Early loss of heterozygosity on 17q Cancer ovarian cancer, Oncogene 7:2069-2072.
9. Foulkes WD, Ragoussis J, Stamp GWH, Allan GJ, Trowsdale J (1993) Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br J Cancer 67:551-559.
10. Foster KA, Harrington P, Kerr J, Russel P, DiCioccio RA, Scott Jacobs I, Chenivex-Trench G, Ponder BAJ, Gayther SA (1996) Somatic and Germaline mutation of the BRCA2 gene in sporadic ovarian cancer. Cancer Res 56:3622-3625.
11. Fugita M, Enomoto T, Inoue M, Tanizawa O, Okai M, Rice JM, Nomura T (1994) Alteration of the TP53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial rumors of the human ovary, Jpn J Cancer Res 85:1247-1256.
12. Gabra H, Taylor L, Cohen BB, Lessels A, Eccles DM, Leonard RCF, Smyth JF, Steel CM (1995) Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumors. Br J Cancer 72:367-375.
13. Gallion HH, Powell DE, Morrow JK, Pieretti M, Case E, Turker MS, DePriest PD, Hunter JE, van Nagell JR (1992) Molecular changes in human epithelial ovarian lalignancies. Gynecol Oncol 47:137- 142.
14. Greenwald BD, Harpaz N, Yin J, Huan Ym Tong Y, Brown VL, McDaniel T, Newkirk C, Resau JH, Meltzer SJ (1992) Loss of heterozygosity affecting P53, Rb. and medape tumor suppressor gene loci in dysplastic and cancerous ulcerative calitis. Cancer Res 52:741-745.
15. Hosking L, Trowsdale J, Nicolai H, Solomon E, Faulkes W, Stamp G Signer E, Jeffreys A (1995) A samatic BRCA1 mutation in an ovarian tumor. Nature Genet 9:343-344.
16. lehikawa Y, Nishida M, Suzuki H, Yoshida S, Tsunoda H, Kubo T, uchida K, Mowa M (1994) Mutation of K-fas Protooneogene is associated with histological subtype in human mucinous ovarian tumors, Cancer Res 554:33-35.
17. Jacobs I, Smith S, Wiseman R, Futical P, Harrington T, Osborne R, Leech V, Molyneux A, Berchuck A, Ponder B, Bast R (1993) A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus, Cancer Res 53;1218-1221.
18. Jenkins RB, Bartelt D, Stalboerger P, Persons D, Dahl RJ, Podratz K, Keeney G, Hartmann L (1993) Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet Cytogenet 71:76-86.
19. Jones MH, Nakamuraq Y (1992) Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosom Cancer 5:89-90.
20. Kacinski BM, Carter D, Mittai K, Yee LD, Seata KA, Donofrio L, Chambers SK, Wang K, Yang-Feng T, Rahrschneider LR, Rothwell VM (1990) Ovarian adenocarcinomas express fms-complementary transcripts and fms-antigen, often with coexpression if CSF-1, Am J Pathol 137:135-147.
21. Kahn SM, Jiang W, Culberrson TA, Weinstein IS, Wlliams GM, Tomita N, Ronai Z (1991) Rapid and sensitive nonradioactive detection of mutant K-ras genes via "enriched" PCR amplification. Oncogene 6:1079-1083.
22. Kupryjanczyk J, Bell D, Dimeo D, Beauchamp R, Thor AD, Yandell DW (1995) P53 Gene analysis of ovarian borderline rumors and stage 1 carcinomas, Hum Pathol 26:387-392.
23. Leary JA, Chenevix-Trench G, Kerr J, Doris JP, Hurst T, Houghton CRS, Friedlander ML (1995) Increased expression of the NME1 gene is associated with metastasis in epithelial ovarian cancer. Int J Cancer 64:189-195.
24. Leggett BA, Young JP, Buttenshaw R, Thomas LR, Young B, Chenevix-Trench G, Searle J, Ward M (1995) Colorectal carcinmas show frequent allelic loss on the long arm of chromosome 17 with evedence for a specific target region, Br J Cancer 71:1070- 1073.
25. Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilberrson J, Foster C, Marshall CJ (1991) Multiple L-ras codon 12 mutation in cholangiocarcinimas demonstrated with a sensitive polymerase chain reaction technique, Cancer Res 51:3497-3502.
26. Linnenbach AJ, Pressler LB, Seng BA, Kimmel BS, Tomaszewski JE, Malkowicz SB (1993) Characterization of chromosome 9 deletions in transitional cell carcinoma by microsarellite assay, Hum Mol Gener 2:1407-1411.
27. Louis DD, von Deimiling A,Seizinger BR(1993) A(CA)n dinucleotide repent assay for evaluaing loss of hererozygosity in small and archival human brain tunmor specimens. Am J Pathol 141:777-782.
28. Mazars R, Pujot P, Maudelonde T, Jeanterur P, Theiller C (1991) p53 Mutations in ovarian cancer a late event? Oncogene 6;1685-1690
29. Merajver SD, Pham TM, Caduff RF, Chen M, poy EL, Cooney KA, Weber BL, Collins FS, Johnstone C, Frank TS (1995) Somatic, mutations in the BRCAI gene in spordaic ovarian tumors,Nature Gener 9:439-443.
30. Milner B, Allan L, Eccles D, Kitchener H, Leonard R, Kelly K, Parkin D, Haites N (1993) p53 Mutation is a common genetic event in ovarian carcinoma. cancer Res 53:2128-2132.
31. Mok SC-H,Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, Berkowitz, RS, Tsao S-W (1993) Mutations of K-ras protooncogene in himan ovarian epithelial tumors of borderline malignancy Cancer Res 53:1489-1492.
32. Orpahnos V, McGown G, Hey Y,Thorncroft M, Santibanezkoref M, Russlell SEH, Hickey I, Atkinson RJ, Boyle JM (1995) Allelic imbalance of chromosome 6q in ovarian tumors, Br J Cancer 71:666-669
33. Phillips N, Zeigler M, Saha B, Xynos F (1993) Allelloss on chromnosome 17 in human ovarian cancer. Inc J Cancer 54:85-91.
34. Pieretti M, Powell DE, Gallion HH, Case EA, conway PS, Thrker MS (1995) Fenetic alterations on chromosome 17 distinguish dufferent types of epithelial ovarian tumors. Hum Pathhol 26:393- 397
35. Powell DE, Puls L, van Nagell J (1992) Does benign to malignant transformations occur ? Hum Pathol 23:846-847.
36. Rimessi P, Gualandi F, Morelli C, Trabanelli C, Wu Q, possari L, Montesi M, Barrett JC, Bargbanti-Brodano G (1994) Transfer of human chromosome 3 to an ovarian carcinoma cell line identities there regions on 3p involved in ovarian cancer. Oncogene 9:3467-3474
37. Rodabaugh K-J, Blanced G, Weleb WR, Bell DA, Berkowitz RS, Mok SC (1995) Detailed mapping of chromosome 6q in borderline epithelial ovarian tumors. Cancer Res 55:2169-2172
38. sandhu AK, Kaur GP, Athwal RS (1993) Identification of tumor suppressor genes in jovarian careinomas by chromsome transfer, AM J Hum Genet53:(Suppl):A1533.
39. Sato T, Saito H, Morita R, Koi s, Lee JH, Nakamura Y (1991) Allelotype of human jovarian cancer, Cancer Res 51:5118-5122.
40. Scully RE (1997) Ovarian tumors: A review. Am J Pathol 87:686-720.
41. Shelling AN, Ciooke IE, Ganesan TE (1995) The genetic analysis of ovarian cancer. Br J Cancer 72:521-527
42. Takahashi H, Behbakhr K, McGovern P, Chin HC, Couch FJ, Weber BL, Friedman LS, King MC, Furosato M, LiVolsi VA (1995) Mutation analysis of the BRCAI gene in ovarian cancer. Cancer Res 55:2998-3002.
43. Tashiro H, Miyazake K Okamura H, Iwai A, Fukumoro M (1992) c-mye Over experssion human primary ovaran tumors, its relevance to tumor progression. Int J Cancer 50:828-833.
44. Tenriello MG, Evina M, Linnoifa RI, Henry M, Nash JD, Park RC, Birrer MJ (1993) p53 Ad Ki-ras gene mutationsin epithelial ovrain neoplasms. Cancer Res 53:3103-3108.
45. Vandamme B, Lissens W, Amfo K, De Sutter P, Bourgain C, Vamos E, De Greve J (1992) Deletion of chromosome 11p13-11p15,5 sequences in invasive human ovarian cancer is a subetonal progression factpr, Camcer Res 52:6646-6652
46. Van't Veer L, Ban den Berg-Bakker L, Hermens R, Deprez R, Schrier P (1998) Jogj frequency of mas oncogene activation detected in the BIH3T3 tumorigenicity assay, Onogene Res 3:247-254.
47. Yoshinoi K, fugita M, Nakashima R, Inoue M, Okudaira Y, Ozaki M, Enomota T. (1995) Mutarions of the MTSI/GDKN2 gene in the neoplasms of the human reproductivae tract, Proc Am Assoc Cancer Res 36:A3475.
48. Young J, Searlt J, stitz R, Cowen A, Ward M, Chenvix-Trench G (1992) Loss of heterozygosity at the human RAPIA/krre-1 locus is a rare event in colorectai tumors.Cancer Res 52:285-289
49. Zheng J, Benedier WF, Xu H-J, Hu S-X, Kim TM, Veliceseu M, Wan M, Cofer KF, Dubeau L (1995) Genetic disparity between morphologically benign eysts coniguous to ovarian carcinomas and solitaruy eystadenomas. J Natl Cancer Inst 87:1146-1153
50. Zweizig S, Zheng J, Wan M, Kim TM, VeliceseuM, Gosewehr J, Dubeau L (1995) New insights into the genetics of human ovarian epithelial tumor development. In Sharp F, Mason P, Blackett T, Berel J (eds): Ovarian Cancer 3, London: Chapman and Hall, pp 61-76.